BioFocus Creates Novel Diverse Screening Library
Complete the form below to unlock access to ALL audio articles.
BioFocus has announced that it has enhanced its diverse screening library through new compound supply agreements with InterBioScreen, Enamine and ChemBridge.
BioFocus now offers one of the most powerful screening platforms in the industry with over 900,000 unique chemical compounds and approximately 100,000 probes from natural sources.
Under the agreements BioFocus has selected a total of 350,000 new compounds. These compounds will replace a portion of the current screening library, resulting in a collection with significantly increased novelty, structural diversity and lead likeness, while increasing its overall solubility profile.
“Integrating our screening collection with our assay expertise has provided our clients with a platform that has the size and flexibility to deliver on their hit-finding campaigns”, said Kate Hilyard, Vice President Biological Sciences BioFocus.
Hilyard continued, “This latest round of compound acquisition demonstrates our commitment to maintaining our reputation as a leading partner in drug discovery”.
